Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
197
Frequently Asked Questions
What is market cap of Asensus Surgical Inc?
The market cap of Asensus Surgical Inc is $155.53M
What is the 52 week high for Asensus Surgical Inc?
The 52 week high for Asensus Surgical Inc is $1.18.
What is the 52 week low for Asensus Surgical Inc?
The 52 week low for Asensus Surgical Inc is $0.28.
What is Asensus Surgical Inc stock price today?
Asensus Surgical Inc' stock price today is $0.65.
What is the pe ratio of Asensus Surgical Inc?
The PE ratio of Asensus Surgical Inc is -2.03.
What is the price to book ratio of Asensus Surgical Inc?
The price to book ratio of Asensus Surgical Inc is 1.5453.
What is Asensus Surgical Inc's EBITDA?
Asensus Surgical Inc's EBITDA is -64.287.
What is the 50-day moving average of Asensus Surgical Inc?
The 50-day moving average of Asensus Surgical Inc is 0.7168.